Oral Enteral Nutrition Feeding in Alzheimer's Patients
- Disease/Condition
- Alzheimer Disease
- Drug/Device/Intervention
- Conventional Care
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- Muhammad
- Funder
- Ahmadu Bello University Teaching Hospital
- Phase
- N/A
- Start date
- Mar 01, 2024
- End date
- Jun 01, 2024
- Enrollment
- 80 participants
Level of Hemoglobin,Level of Serum albumin,Level of Total serum protein,Level of Serum prealbumin
This is a prospective multicenter study with Alzheimer's patients with dysphagia. Patients
 enrolled are randomly divided equally into the observation group and the control group. All
 patients receive conventional care, and the observation group received Intermittent
 Oral-esophageal Tube Feeding while the control group received Nasogastric Tube Feeding for
 enteral nutrition support. Baseline information (demographics, medical history, etc.),
 nutritional status at admission and after treatment, depression, dysphagia, and quality of
 life after treatment are compared.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06301750
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06301750 through Pure Global AI's free database. This phase not specified trial is sponsored by Muhammad and is currently Not yet recruiting. The study focuses on Alzheimer Disease. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.